ENCODE (ENCyclopedia Of DNA Elements)

02/23/2022

**Tweet Shoutout from Jian Ma**

We're announcing Nucleome Browser, an integrative & multimodal data navigation platform for 4DNucleome & the broad community.
This tool is a result of tremendous creativity & herculean effort over the years from , in collab. w/ 1/n
https://twitter.com/biorxivpreprint/status/1496300615059841026?s=20&t=YAcrV2slBshglNUvP__tMw

02/18/2022

RFA Announcement!

Link to RFA Info: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-001.html

The Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions initiative is soliciting applications to support collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in developing, implementing, or disseminating innovative and effective interventions to prevent, reduce, or eliminate health disparities and advance health equity.

Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in addressing health disparities and advancing health equity. To be eligible for this FOA, institutions must be a domestic institution located in the United States and its territories which:

have received less than $25 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER; and
award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences; and have a historical and current mission to educate students from any of the populations that have been identified as underrepresented in biomedical research as defined by the National Science Foundation NSF (http://www.nsf.gov/statistics/wmpd/)

Women, Minorities, and Persons with Disabilities in Science and Engineering: 2021 provides statistical information about the participation of these three groups in science and engineering education and employment. Data and figures in this digest are organized into the following topical areas: enroll...

02/18/2022

Exciting news! The RFA-RM-22-008 was just re-issued!

Goal: transform culture at NIH-funded extramural institutions by building a community of scientists committed to diversity and inclusive excellence!

Who: individuals who are competitive for an advertised research tenure-track, equivalent faculty position, meet the criteria for NIH-defined Early Stage Investigators, and have demonstrated a strong commitment to promoting diversity and inclusive excellence!

For more information:

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) RFA-RM-22-008. RMOD

01/11/2022

**New Funding Opportunity**

Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets!

The NIH Common Fund supports transformative research programs that generate new technologies, methods, and data. Many of these programs produce rich public data sets containing various multi-dimensional molecular and phenotypic data from a range of sources. To maximize the impact of these data, engage a diverse community of end-users for broader adoption of these data sets, and to obtain feedback from award recipients to enhance the data resources, the Common Fund plans to support small research projects (R03) using data sets from two or more Common Fund programs. Awards are intended to enable novel and compelling biological questions to be formulated and addressed, and/or to generate cross-cutting hypotheses for future research.

The goals of this funding opportunity announcement (RFA-RM-22-007) are to 1) promote the use of Common Fund data sets by supporting pilot studies based on analyses across two or more Common Fund program data sets; 2) enhance the utility of existing Common Fund data sets by developing workflows, analytic and simulation tools which will enable simultaneous analysis of multiple Common Fund data sets; and 3) demonstrate the added-value of integrating multiple Common Fund data resources in addressing biomedical research questions.

Funding Opportunity Announcement: http://ow.ly/v9ra50Hsm5s

Important Dates
Applications are due February 18, 2022, by 5:00 pm local time of the applicant organization.

For more info: http://ow.ly/frp950Hsm5t

You can contact the CFDE team at [email protected] with any additional questions.

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) RFA-RM-22-007. RMOD

12/08/2021

**RFA Announcement**

Supporting Talented Early Career Researchers in Genomics
RFA-HG-22-001

For more information please use the link below:

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) RFA-HG-22-001. NHGRI

12/06/2021

**Bespoke Gene Therapy Consortium: Request for Proposals and a Disease Nomination Form**

In order to support the newly-launched Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC), the Foundation for the National Institutes of Health (FNIH) has released multiple opportunities for researchers, clinicians, and patient advocates to contribute to the work of the consortium.

The BGTC is seeking high-throughput screens or other promising developments to optimize individual steps of the AAV vector generation and human gene expression pathways. To read the AAV Vector Generation RFP, click here. To read the AAV Gene Expression RFP, click here: http://ow.ly/aF9X50H4c74.

The BGTC Steering Committee also seeks information on rare diseases and disorders that could be candidates for AAV gene therapy trials conducted by the BGTC. A Disease Nomination form is has been made available to obtain information about the rare disease and the patient population, prior R&D work, and high-level factors that would be considered in designing a clinical trial. Patient groups, clinicians, and researchers are strongly encouraged to collaborate on preparing a disease or disorder nomination. Selected nominations will be invited to submit a full RFP at a later date. To access the Disease Nomination form, click here.

The FNIH plans to hold informational webinars about each of these opportunities, with details to follow on the BGTC website. RFP submissions and completed Disease Nomination forms are due by February 18, 2022 to [email protected].

NIH Press Release: http://ow.ly/UuWT50H4c70
NIH BGTC webpage: http://ow.ly/Xx7m50H4c73

FNIH Press Release: http://ow.ly/uwZb50H4c72
FNIH BGTC webpage: http://ow.ly/cBtC50H4c71

Breadcrumb Home Bespoke Gene Therapy Consortium (BGTC) Bespoke Gene Therapy Consortium (BGTC) Skip This Section The Problem With the current commercial drug development model, companies cannot recover the costs required to develop gene therapies to treat rare and ultra-rare genetic diseases, because...

11/04/2021

**National Science F ANNOUNCEMENT**

The National Science Foundation is hosting an Ideas Lab next year: Dark Dimensions of the RNA Regulome (D2R2) An Ideas Lab Activity.

This event will take place in person (location TBD), in the vicinity of NSF headquarters in Northern Virginia from June 13 - 17, 2022.

For more information:

Innovating and migrating proposal preparation and submission capabilities from FastLane to Research.gov is part of the ongoing NSF information technology modernization efforts, as described in Important Notice No. 147. In support of these efforts, research proposals submitted in response to this pro...

09/28/2021

Check out the Virtual 2021 Synthetic Biology Consortium Meeting

Dates: November 4-5, 2021

This meeting will be focusing on Synthetic Biology for Biomedicine!

Key sessions will include:
• Engaging with FDA stakeholders
• Showcase of research from Synthetic Biology Consortium grantees
• Networking with NIH Program staff
• Trainee-focused grant/technical writing panel

For more information and to register for this virtual meeting, please visit

The 2021 Synthetic Biology Consortium Meeting is scheduled for November 4-5, 2021 and will be held virtually. The Synthetic Biology Consortium meets annually to facilitate important discussions focused on synthetic biology and cultivate a culture of synthetic biology research at the NIH. The 2021 Sy...

09/20/2021

**Shout out to the GREAT program**

The GREAT program pre-application webinar is occurring on October 6th at 1pm.

The focus of the GREAT program is to provide exposure to genomics research focused towards undergraduate students enrolled at MSIs or IDeA-eligible institutions.

Please refer to the RFA and the website for more information!

The RFA is linked here:

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed) RFA-HG-21-033. NHGRI

09/02/2021

! ENCODE started in September 2003 and is now in its final stages in September of 2021! 18 years of science and innovation have taken place thanks to the ENCODE team and NHGRI

08/27/2021

*Loan Repayment Program*

The NIH offers Loan Repayment Programs (LRPs) designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research centers.

The LRPs counteract that financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.

For more information about the program and the application process, please visit http://ow.ly/rmqg50FZJQu.

DLR Celebrates the 20th Anniversary of the Health Disparities Research & Clinical Research for Individuals from Disadvantaged Backgrounds LRPs